| Prevention of HIV-1 infection with early antiretroviral therapy MS Cohen, YQ Chen, M McCauley, T Gamble, MC Hosseinipour, ... New England journal of medicine 365 (6), 493-505, 2011 | 8933 | 2011 |
| Recovery of replication-competent HIV despite prolonged suppression of plasma viremia JK Wong, M Hezareh, HF Gunthard, DV Havlir, CC Ignacio, CA Spina, ... Science 278 (5341), 1291-1295, 1997 | 2658 | 1997 |
| Treatment with indinavir, zidovudine, and lamivudine in adults with human immunodeficiency virus infection and prior antiretroviral therapy RM Gulick, JW Mellors, D Havlir, JJ Eron, C Gonzalez, D McMahon, ... New England Journal of Medicine 337 (11), 734-739, 1997 | 2488 | 1997 |
| The end of AIDS: HIV infection as a chronic disease SG Deeks, SR Lewin, DV Havlir The lancet 382 (9903), 1525-1533, 2013 | 2327 | 2013 |
| Memory CD8+ T cells vary in differentiation phenotype in different persistent virus infections V Appay, PR Dunbar, M Callan, P Klenerman, GMA Gillespie, L Papagno, ... Nature medicine 8 (4), 379-385, 2002 | 1965 | 2002 |
| Antiretroviral therapy for the prevention of HIV-1 transmission MS Cohen, YQ Chen, M McCauley, T Gamble, MC Hosseinipour, ... New England Journal of Medicine 375 (9), 830-839, 2016 | 1926 | 2016 |
| Asymptomatic transmission, the Achilles’ heel of current strategies to control Covid-19 M Gandhi, DS Yokoe, DV Havlir New England journal of medicine 382 (22), 2158-2160, 2020 | 1399 | 2020 |
| HIV-Specific Cd8+ T Cells Produce Antiviral Cytokines but Are Impaired in Cytolytic Function V Appay, DF Nixon, SM Donahoe, GMA Gillespie, T Dong, A King, ... The Journal of experimental medicine 192 (1), 63-76, 2000 | 1150 | 2000 |
| Sexual transmission and propagation of SIV and HIV in resting and activated CD4+ T cells ZQ Zhang, T Schuler, M Zupancic, S Wietgrefe, KA Staskus, KA Reimann, ... Science 286 (5443), 1353-1357, 1999 | 1145 | 1999 |
| Class-sparing regimens for initial treatment of HIV-1 infection SA Riddler, R Haubrich, AG DiRienzo, L Peeples, WG Powderly, ... New England Journal of Medicine 358 (20), 2095-2106, 2008 | 876 | 2008 |
| Nevirapine resistance mutations of human immunodeficiency virus type 1 selected during therapy DD Richman, D Havlir, J Corbeil, D Looney, C Ignacio, SA Spector, ... Journal of virology 68 (3), 1660-1666, 1994 | 760 | 1994 |
| Tuberculosis in patients with human immunodeficiency virus infection DV Havlir, PF Barnes New England journal of medicine 340 (5), 367-373, 1999 | 755 | 1999 |
| Timing of antiretroviral therapy for HIV-1 infection and tuberculosis DV Havlir, MA Kendall, P Ive, J Kumwenda, S Swindells, SS Qasba, ... New England Journal of Medicine 365 (16), 1482-1491, 2011 | 736 | 2011 |
| Effects of early versus delayed initiation of antiretroviral treatment on clinical outcomes of HIV-1 infection: results from the phase 3 HPTN 052 randomised controlled trial B Grinsztejn, MC Hosseinipour, HJ Ribaudo, S Swindells, J Eron, ... The Lancet infectious diseases 14 (4), 281-290, 2014 | 652 | 2014 |
| Prevalence and predictive value of intermittent viremia with combination HIV therapy DV Havlir, R Bassett, D Levitan, P Gilbert, P Tebas, AC Collier, MS Hirsch, ... Jama 286 (2), 171-179, 2001 | 481 | 2001 |
| Prophylaxis against Disseminated Mycobacterium avium Complex with Weekly Azithromycin, Daily Rifabutin, or Both DV Havlir, MP Dubé, FR Sattler, DN Forthal, CA Kemper, MW Dunne, ... New England Journal of Medicine 335 (6), 392-398, 1996 | 427 | 1996 |
| Viral dynamics of acute HIV-1 infection SJ Little, AR McLean, CA Spina, DD Richman, DV Havlir The Journal of experimental medicine 190 (6), 841-850, 1999 | 417 | 1999 |
| Effect of treatment, during primary infection, on establishment and clearance of cellular reservoirs of HIV-1 MC Strain, SJ Little, ES Daar, DV Havlir, HF Günthard, RY Lam, OA Daly, ... The Journal of infectious diseases 191 (9), 1410-1418, 2005 | 409 | 2005 |
| High-dose nevirapine: safety, pharmacokinetics, and antiviral effect in patients with human immunodeficiency virus infection D Havlir, SH Cheeseman, M Mclaughlin, R Murphy, A Erice, SA Spector, ... Journal of Infectious Diseases 171 (3), 537-545, 1995 | 385 | 1995 |
| Advancing global health and strengthening the HIV response in the era of the Sustainable Development Goals: the International AIDS Society—Lancet Commission LG Bekker, G Alleyne, S Baral, J Cepeda, D Daskalakis, D Dowdy, ... The Lancet 392 (10144), 312-358, 2018 | 362 | 2018 |
